Eli Lilly CEO David Ricks bought just over $1 million of Lilly shares in the open market Tuesday following the sharp drop in ...

As President Donald Trump works to move sky-high U.S. drug prices closer to those in other developed countries, Eli Lilly ...

CNBC’s Angelica Peebles and Eli Lilly chairman and CEO David Ricks join 'Squawk Box' to discuss the company's quarterly earnings results, late-stage trial data on its experimental obesity pill ...

Aug 7 - Eli Lilly posted blockbuster Q2 results but saw its stock slide about 7% on mixed Q2 Earnings news. The Indianapolis-based pharma giant delivered adjusted EPS of $6.31 and ...

One of them is the pharmaceutical industry. However, some major executives in the sector are not optimistic, including Eli Lilly 's (NYSE: LLY) CEO, David Ricks. Start Your Mornings Smarter!

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 ...

Eli Lilly CEO Dave Ricks on Thursday said the drugmaker can help "respond" to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom. Stream ...

David Ricks is CEO of Eli Lilly, the most valuable drugmaker in the world by market cap and a company on course to become the first $1 trillion pharma firm.